<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23723674</article-id><article-id pub-id-type="pmc">3665207</article-id><article-id pub-id-type="publisher-id">AYU-33-547</article-id><article-id pub-id-type="doi">10.4103/0974-8520.110532</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title><italic>Gokshuradi Vati</italic> and <italic>Dhanyaka-Gokshura Ghrita Matra Basti</italic> in the management of Benign Prostatic Hyperplasia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bhalodia</surname><given-names>Shreyas G.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Bhuyan</surname><given-names>Chaturbhuj</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Sanjay Kumar</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Dudhamal</surname><given-names>Tukaram S.</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib></contrib-group><aff id="aff1">Lecturer, Department of Sharira Rachana, KVG Ayurveda Medical College, Sullia, Karnataka, India</aff><aff id="aff2"><label>1</label>Director, Centre for Care of Ano-Rectal Research by Indian System of Medicine and Allied Sciences, Bhubneshwar, Odisa, India</aff><aff id="aff3"><label>2</label>Associate Professor and I/C Head, Department of Shalya Tantra, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India</aff><aff id="aff4"><label>3</label>Assistant Professor, Department of Shalya Tantra, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Shreyas G. Bhalodia, Block No 201, My Nest Apartment, N/R ICICI Bank, Motibag Road, Junagadh - 362 001, Gujarat, India. E-mail: <email xlink:href="shreyas.ayurved@gmail.com">shreyas.ayurved@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2012</year></pub-date><volume>33</volume><issue>4</issue><fpage>547</fpage><lpage>551</lpage><permissions><copyright-statement>Copyright: &#x000a9; AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Benign Prostatic Hyperplasia (BPH) is a burning senile problem of elderly men and no definitive conservative cure is available. The present available surgical and minimal invasive methods have their own limitations. Hence, to find out a suitable Ayurvedic approach, an effort has been made towards the management of BPH, In this study, 32 selected patients of <italic>Mootraghata</italic> at par to BPH were divided into three groups randomly and treated accordingly. In group A, <italic>Gokshuradi</italic> compound (GC) <italic>Vati</italic> (GV) 500 mg was given three times a day with luke-warm water after food; while in group B, <italic>Dhanyaka-Gokshura Ghrita</italic> (DGG) as <italic>Matra Basti</italic> (MB) of 60 ml, once in a day, just after lunch and combined therapy of both formulations in group C was administered. Out of 32 patients, total 30 patients (10 in each group) were completed the treatment course of 21 days. In results, 54.09% improvement was seen in group C, 45.67% in group A and 47.99% in group B. The size of prostate gland was found reduced highly significant in group C. Hence, it is concluded that combined therapy of GV and DGG MB is beneficial without developing any adverse drug reactions and can be prescribed safely for <italic>Mootraghata</italic> (BPH).</p></abstract><kwd-group><kwd>Benign prostatic hyperplasia</kwd><kwd><italic>Dhanyaka-Gokshura Ghrita</italic></kwd><kwd><italic>Gokshuradi Vati</italic></kwd><kwd><italic>Matra Basti</italic></kwd><kwd><italic>Mootraghata</italic></kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>Introduction</title><p>The term <italic>Mootraghata</italic> stands for low urine output due to obstruction in the passage of urine. It can be considered as a syndrome, because it covers most of the pathological entity of the urinary system into 12 types[<xref ref-type="bibr" rid="ref1">1</xref>] except urolithiasis and reflect the symptoms of retention of urine, incomplete voiding, dribbling, hesitancy, increased frequency of micturition, weak stream, and nocturia. These features are related to the Lower Urinary Tract Symptoms (LUTS)[<xref ref-type="bibr" rid="ref2">2</xref>] and Bladder Outflow Obstruction (BOO),[<xref ref-type="bibr" rid="ref3">3</xref>] hence, it can be co-related with the disease Benign Prostatic Hyperplasia (BPH) at modern parlance.</p><p>BPH is a senile disorder of the geriatric men with histologically proven high incidence of 92.97% (<italic>n</italic> = 185) and 93.3% (<italic>n</italic> = 200)[<xref ref-type="bibr" rid="ref4">4</xref>] in India. For this notorious problem there is no concrete conservative measure available until now. BPH involves multi-factorial pathogenesis caused by not only involvement of prostate and bladder, but also involves the hypothalamus-pituitary-gonads axis. The scope for medical therapy is still high because of the limitation of surgical approaches due to greater morbidity and failure to consistently achieve a successful outcome.[<xref ref-type="bibr" rid="ref5">5</xref>] Therefore, to find out solutions through minimal invasive surgical techniques and use of phytotherapeutic treatment as an alternative approach for BPH has been taken as a research problem in this particular field. In this regard, for the treatment of LUTS/BPH, phytotherapeutic agents in USA have gained widespread usage since 1990.[<xref ref-type="bibr" rid="ref6">6</xref>]</p><p>In the context of manifestation of <italic>Mootraghata</italic>, developed due to deranged function of <italic>Vayu</italic>, particularly <italic>Apana Vayu</italic> leads to this condition. The authentic treatment for deranged <italic>Vata</italic> is the <italic>Basti</italic> and among them the <italic>Matra Basti</italic> (MB) is a safe one, which can be adopted without any restriction.[<xref ref-type="bibr" rid="ref7">7</xref>] <italic>Mootraghata</italic> can be correlated to BPH and is caused due to vitiated <italic>Vata</italic> and <italic>Kapha</italic> which involve <italic>Mootravaha Srotodushti</italic>. Present clinical study was planned as per management principles[<xref ref-type="bibr" rid="ref8">8</xref>] to evaluate the clinical efficacy of Gokshuradi Vati (GV) orally and Dhanyaka-Gokshura Ghrita (DGG) Matra Basti (MB) in the management of Mootraghata with reference to BPH.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Selection of patients</title><p>Total 32 male patients having signs and symptoms of <italic>Mootraghata</italic> (BPH) were selected randomly from outpatient department of Shalya Tantra and from two special diagnostic camps irrespective of religion and occupation.</p></sec><sec id="sec2-2"><title>Inclusion criteria</title><p>
<list list-type="bullet"><list-item><p>Male patients of age - 50 to 80 years.</p></list-item><list-item><p>Patients having signs and symptoms of <italic>Mootraghata</italic> (BPH).</p></list-item></list>
</p></sec><sec id="sec2-3"><title>Exclusion criteria</title><p>
<list list-type="bullet"><list-item><p>Patients not fulfilling age criteria and those suffering from malignancy, congenital deformities of urogenital tract,</p></list-item><list-item><p>Systemic diseases such as uncontrolled hypertension, diabetes mellitus, liver, renal, and cardiac diseases.</p></list-item></list>
</p></sec><sec id="sec2-4"><title>Diagnostic criteria</title><p>Diagnosis was made on the basis of classical signs and symptoms of <italic>Mootraghata</italic>, per rectal digital examination and on the basis of the findings of Ultra Sonography for Kidney, Ureter, Bladder Region (KUB) and prostate.</p></sec><sec id="sec2-5"><title>Trial drugs</title><p>
<list list-type="bullet"><list-item><p>G<italic>V</italic>: It contains <italic>Punarnava</italic> (<italic>Boerhavia diffusa</italic> L. nom. Cons.) and <italic>Devadaru</italic> (<italic>Cedrus deodara</italic> (Roxb.) G. Don) as additional <italic>Kwatha Dravyas</italic> to classical formulation of <italic>Gokshuradi Guggulu</italic>.[<xref ref-type="bibr" rid="ref9">9</xref>] It was prepared as per <italic>Guggulu Kalpana</italic>.[<xref ref-type="bibr" rid="ref10">10</xref>]</p></list-item><list-item><p>DGG: In this formulation, <italic>Dhanyaka</italic> (<italic>Coriandrum sativum</italic> L.) and <italic>Gokshura</italic> (<italic>Tribulus terrestris</italic> L.) were used as <italic>Kalka</italic> and <italic>Kwatha Dravya</italic>; and cow ghee as <italic>Sneha Dravya</italic>.[<xref ref-type="bibr" rid="ref11">11</xref>] It was prepared as per classical <italic>Snehapaka Kapana</italic>.[<xref ref-type="bibr" rid="ref12">12</xref>]</p></list-item><list-item><p>Both the drugs were prepared and supplied by the Pharmacy, Gujarat Ayurved University, Jamnagar.</p></list-item></list>
</p></sec><sec id="sec2-6"><title>Clinical study design</title><sec id="sec3-1"><title>Grouping and posology</title><p>
<list list-type="bullet"><list-item><p>Patients were divided into three groups by simple random sampling method:</p><p>
<list list-type="order"><list-item><p>Group A: G<italic>V</italic> 500 mg was administered orally three times in a day, with luke-warm water, 30 min. after food.</p></list-item><list-item><p>Group B: DGG was administered as MB of 60 ml, once in a day, just after lunch[<xref ref-type="bibr" rid="ref13">13</xref>] possible at 12.30 pm.</p></list-item><list-item><p>Group C: Combined therapy of GV and DGG MB was administered as per above mentioned schedule.</p></list-item></list>
</p></list-item><list-item><p>Total duration of therapy in each group was of 21 days.</p></list-item><list-item><p>Follow-up period was of 1 month.</p></list-item></list>
</p></sec></sec><sec id="sec2-7"><title>Assessment criteria</title><p>
<list list-type="bullet"><list-item><p>Subjective assessment of results was carried out by scoring pattern of symptoms of <italic>Mootraghata</italic>/BPH and by using International Prostate Symptom Score[<xref ref-type="bibr" rid="ref14">14</xref>] sheet for subjective complaints.</p></list-item><list-item><p>Objective assessment of results was done by Average Urine Flow Rate (AUFR) measurement and USG findings of prostate weight and Post-voidal Residual Urine Volume (PRUV) were considers as objective parameters [<xref ref-type="table" rid="T1">Table 1</xref>].</p></list-item></list>
</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Overall assessment of result</p></caption><graphic xlink:href="Ayu-33-547-g001"/></table-wrap></sec><sec id="sec2-8"><title>Statistical analysis</title><p>For assessing effect of therapy on each subjective and objective parameters, paired &#x02018;<italic>t</italic>&#x02019; test for significance was applied. For comparison among the three groups, for objective parameters un-paired &#x02018;t&#x02019; test is used whereas for subjective parameters Chi-square test with Yate's correction was adopted.</p></sec></sec><sec id="sec1-3"><title>Observations and Results</title><p>Out of 32 patients, 10 in each group were completed the therapy and follow-up period. So, in this study, general observations were made on 32 patients as mentioned in Tables <xref ref-type="table" rid="T2">2</xref>-<xref ref-type="table" rid="T4">4</xref> and results were made on 30 patients as shown in Tables <xref ref-type="table" rid="T5">5</xref>-<xref ref-type="table" rid="T12">12</xref>.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>General observations (<italic>n</italic>=32)</p></caption><graphic xlink:href="Ayu-33-547-g002"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>General observations on subjective findings (<italic>n</italic>=32)</p></caption><graphic xlink:href="Ayu-33-547-g003"/></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>General observations on objective findings (<italic>n</italic>=32)</p></caption><graphic xlink:href="Ayu-33-547-g004"/></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Effect of therapy on subjective parameters in group A (<italic>n</italic>=10)</p></caption><graphic xlink:href="Ayu-33-547-g005"/></table-wrap><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Effect of therapy on objective parameters in group A (<italic>n</italic>=10)</p></caption><graphic xlink:href="Ayu-33-547-g006"/></table-wrap><table-wrap id="T7" position="float"><label>Table 7</label><caption><p>Effect of therapy on subjective parameters in group B (<italic>n</italic>=10)</p></caption><graphic xlink:href="Ayu-33-547-g007"/></table-wrap><table-wrap id="T8" position="float"><label>Table 8</label><caption><p>Effect of therapy on objective parameters in group B (<italic>n</italic>=10)</p></caption><graphic xlink:href="Ayu-33-547-g008"/></table-wrap><table-wrap id="T9" position="float"><label>Table 9</label><caption><p>Effect of therapy on subjective parameters in group C (<italic>n</italic>=10)</p></caption><graphic xlink:href="Ayu-33-547-g009"/></table-wrap><table-wrap id="T10" position="float"><label>Table 10</label><caption><p>Effect of therapy on objective parameters in group C (<italic>n</italic>=10)</p></caption><graphic xlink:href="Ayu-33-547-g010"/></table-wrap><table-wrap id="T11" position="float"><label>Table 11</label><caption><p>Comparative mean effect of therapy in percentage (<italic>n</italic>=30)</p></caption><graphic xlink:href="Ayu-33-547-g011"/></table-wrap><table-wrap id="T12" position="float"><label>Table 12</label><caption><p>Overall effect of therapy (<italic>n</italic>=30)</p></caption><graphic xlink:href="Ayu-33-547-g012"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p><italic>Mootraghata</italic> (BPH) is a most common obstructive urological condition of old age. In pathophysiology of <italic>Mootraghata</italic>, there is involvement of <italic>Mootravaha Srotasa</italic> especially Basti (bladder). It may occur due to complex phenomena such as BOO, LUTS, and BPH. The symptoms of all types of <italic>Mootraghata</italic> may be classified under three groups for clinical assessment of BPH.</p><p>Voiding symptoms include <italic>Pravaahato Shanaih Shanaih</italic> (decreased urine flow rate/weak stream of urine), <italic>Pravaahato Punah Punaha</italic> (increased frequency/urgency of micturition), <italic>Mootrasanga</italic> (retention of urine, acute/chronic), <italic>Srijeda-Alpaalpam</italic> (scanty micturition/dribbling), <italic>Adhahasroto Nirodhanam</italic> (constipation), <italic>Yobhuyah Srashtumichchhati</italic> (hesitancy), etc., which are resembling with LUTS and BOO and generally exist in <italic>Vatakundalika, Mootrasanga, Vatashtheela</italic>, and <italic>Mootrateeta</italic> &#x02013; all are the types of <italic>Mootraghata</italic>.</p><p>Findings of per rectal digital examination such as <italic>Vritta Granthi</italic> (round/oval shaped mass), <italic>Sthira-Ghana-Astheela Vata Granthi</italic> (hard/firm in consistency), and <italic>Unnata Granthi</italic> (convex surface), which are found in <italic>Vatashtheela</italic> and <italic>Mootragrathi</italic>. Hence, these types of <italic>Mootraghata</italic> may be related to be more nearer to the disease of BPH.</p><p>Rest of symptoms of <italic>Mootraghata</italic> which are grouped under the findings of urine examinations such as <italic>Mootram Haridram</italic> (yellow urine), <italic>Mootram Bahalam</italic> (large quantity urine), and <italic>Raktam Mootram</italic> (reddish urine) are found in <italic>Bastikundal, Mootrotsanga, Vatabasti, Mootrajathara, Ushnavata</italic>, and <italic>Mootraukasada</italic> types of <italic>Mootraghata</italic>. These features are helpful in making differential diagnosis of BPH from other pathological conditions.</p><p>Out of total 32 patients registered in this study, maximum number of patients, i.e. 17 (53.13%) were found in age group of 60-80 years because it is the <italic>Sheeryamanadhatvavastha</italic> (elderly age) dominated by <italic>Vata Prakopa</italic>. Remaining patients were above 50 years, i.e. in <italic>Vriddhavastha</italic> (senile age), which is the natural period of <italic>Vata Vriddhi</italic> in the body.[<xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref16">16</xref>] Hence, it is attributed that the provoked Vata is a prime causative factor for manifestation of <italic>Mootraghata</italic>.[<xref ref-type="bibr" rid="ref17">17</xref>] In this study, 59.37% patients had the history of tobacco chewing or smoking. As per the research studies on BPH in Europe, there is no strong evidence for smoking, tobacco chewing and high alcohol intake as the risk-factors for the causing BPH.[<xref ref-type="bibr" rid="ref18">18</xref>] However in Ayurveda, it has been cited that <italic>Teekshna Aushadha</italic> or <italic>Aahara</italic>[<xref ref-type="bibr" rid="ref19">19</xref>] (drugs/diet of strong potency like tobacco) are traced as the leading causative factors for <italic>Mootraghata</italic>. In the present research work, 71.88% patients had positive history of <italic>Adhyashana</italic> and <italic>Vishamashana</italic>. Such kind of dietetic habits lead to formation of <italic>Kleda</italic> and <italic>Aama</italic> in <italic>Dhatus</italic>[<xref ref-type="bibr" rid="ref20">20</xref>] which might be produced <italic>Srotoavarodha</italic> in <italic>Dhatu</italic>. This phenomenon is treated as one of the important factors in the etiopathogenesis of <italic>Mootraghata</italic>. Maximum number of patients, i.e. 56.25% were belonging to <italic>Vata-Kaphaja Prakriti</italic>, the data itself revealed <italic>Dosha</italic> dominancy for individual in older age group and hence it can be presumed that <italic>Prakriti</italic> may play an important role for susceptibility or development of <italic>Mootraghata</italic>. Highest number of patients, i.e. 43.57% had chronicity of 1-3 years which suggests that <italic>Mootraghata</italic> is a slow and gradually disorder and had chronic history of onset [<xref ref-type="table" rid="T2">Table 2</xref>].</p><p>The result of study in group A showed statistically significant relief in all subjective parameters. Further, the trial formulation has given highly significant result by increasing AUFR; significant result was observed in reduction of prostate size while insignificant change was observed over PRUV. Overall, it was concluded that out of 10 patients, 3 patients (30.00%) were shown moderate improvement, while 7 patients (70.00%) were got mild improvement. These results were found due to GV, which possess properties such as <italic>Vatakapha Shamaka, Lekhana, Pachana, Bastishodhana, Mootrala, Grahee, Pramathee</italic> qualities and played vital role in breaching <italic>Samprapti</italic> of <italic>Mootraghata</italic> [Tables <xref ref-type="table" rid="T5">5</xref>, <xref ref-type="table" rid="T6">6</xref>, <xref ref-type="table" rid="T12">12</xref>].</p><p>In group B, all subjective parameters had showed highly significant (<italic>P</italic> &#x0003c; 0.001) relief except in dribbling of micturition feature, which was statistically insignificant. DGG MB showed highly significant result in AUFR, while significant result was found in the reduction in size of enlarged prostate gland and in feature of PRUV the result was insignificant. Finally, out of 10 patients, 4 patients (40.00%) had shown moderate improvement and 6 patients (60.00%) got mild improvement. The deranged function of <italic>Apana Kshetra</italic> would have been corrected by virtue of <italic>Mootrala, Tridoshahara</italic>, and <italic>Basti</italic> Shodhana properties of DGG MB. It may be attributed also that the nourishment of the nervous systems through Enteric Nervous System (ENS) and Central Nervous System (CNS) theory[<xref ref-type="bibr" rid="ref21">21</xref>] would have been much impact on bladder physiology and in correction of pathogenesis of BOO [Tables <xref ref-type="table" rid="T7">7</xref>, <xref ref-type="table" rid="T8">8</xref>, <xref ref-type="table" rid="T12">12</xref>].</p><p>Group C showed statistically highly significant relief in all subjective parameters. Combined therapy of GV and DGG MB in this group had shown highly significant improvement in urine flow rate and reduction in size of the prostate gland followed by significant reduction in PRUV. Overall in this group, out of 10 patients, 7 patients (70.00%) had got moderate improvement and 3 patients (30.00%) had shown mild improvement. Hence, group C showed better result in all parameters due to the synergistic effect of GV and DGG MB [Tables <xref ref-type="table" rid="T9">9</xref>, <xref ref-type="table" rid="T10">10</xref>, <xref ref-type="table" rid="T12">12</xref>].</p><p>As per assessment, group C showed better improvement in objective parameters (36.41%) than group A (20.90%) and group B (26.70%). However, when data was analyzed statistically with un-paired &#x02018;<italic>t</italic>&#x02019; test for three group comparison, insignificant difference was observed. In the same way, for subjective parameters, group C showed percentage wise better results, i.e. 56.33% than group A (51.50%) and group B (51.60%). However, when data was analyzed statistically with Chi square test with Yates correction; insignificant difference between all the groups was recorded [<xref ref-type="table" rid="T11">Table 11</xref>].</p><p>The <italic>Samyak Yoga Lakshanas</italic> of MB were observed in 95.00% of patients due to <italic>Deepana, Pachana</italic>, and <italic>Niratyaya</italic>[<xref ref-type="bibr" rid="ref7">7</xref>] (without complications) effects of DGG MB. No adverse drug reactions were observed during this clinical study.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p><italic>Gokshuradi Vati</italic> and <italic>Gokshura-Dhanyaka Ghrita Matra Basti</italic> are proven clinically to be safe and effective therapy in the management of <italic>Vriddhavastha-Janya Mootraghata</italic> i.e. BPH.</p></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sushruta</surname></name></person-group><person-group person-group-type="editor"><name><surname>Vaidya Yadavaji</surname><given-names>Trikamji Aacharya</given-names></name></person-group><source>Sushruta Samhita, Uttar Tantra, Mutraghata Pratishedhahyaya, 58/3-4</source><year>2008</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashana</publisher-name><fpage>787</fpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Neal</surname><given-names>DE</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Williams</surname><given-names>NS</given-names></name><name><surname>Bulstrode</surname><given-names>O'Connell</given-names></name></person-group><article-title>The prostate and seminal vesicles</article-title><source>Bailey and Love's Short Practice of Surgery</source><year>2008</year><edition>25th ed</edition><publisher-loc>London</publisher-loc><publisher-name>Hodder Arnold</publisher-name><fpage>1345</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><collab>Ibidem</collab><article-title>Bailey and Love's Short Practice of Surgery</article-title><fpage>1346</fpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bid</surname><given-names>HK</given-names></name><name><surname>Konwar</surname><given-names>R</given-names></name><name><surname>Sing</surname><given-names>V</given-names></name></person-group><article-title>Benign prostatic hyperplasia: Is it a growing public health concern for India?</article-title><source>Indian J Med Sci</source><year>2008</year><volume>62</volume><fpage>373</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">18923217</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wein</surname><given-names>AJ</given-names></name><name><surname>Kavoussi</surname><given-names>LR</given-names></name><name><surname>Novick</surname><given-names>AC</given-names></name><name><surname>Partin</surname><given-names>AW</given-names></name><name><surname>Peters</surname><given-names>CA</given-names></name></person-group><article-title>Campbell-Walsh Urology</article-title><year>2007</year><edition>9th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>W.B. Saunders Company</publisher-name><fpage>1225</fpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><collab>Ibidem</collab><article-title>Campbell-Walsh Urology</article-title><fpage>1999</fpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Vaidya Yadavaji</surname><given-names>Trikamji Aacharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita, Siddhi Sthana, Dhamargava Kalpaadhyaya, 4/53</source><year>2002</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrita Sansthana</publisher-name><fpage>701</fpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sushruta</surname></name></person-group><person-group person-group-type="editor"><name><surname>Vaidya Yadavaji</surname><given-names>Trikamji Aacharya</given-names></name></person-group><source>Sushruta Samhita, Uttar Tantra, Mutraghata Pratishedhahyaya, 58/27</source><year>2008</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbhaarati Prakashana</publisher-name><fpage>789</fpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sharangadhara</surname></name></person-group><person-group person-group-type="editor"><name><surname>Pandita P S</surname><given-names>Vidhyasagar</given-names></name></person-group><source>Sharangadhara Samhita, Madhyama Khanda, 6/22</source><year>2006</year><edition>1st ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashana</publisher-name><fpage>82</fpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><collab>Ibidem</collab><article-title>Sharangadhara Samhita, Madhyama Khanda;</article-title><fpage>197</fpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bhavamishra</surname></name></person-group><person-group person-group-type="editor"><name><surname>Pandit Shri</surname><given-names>B S Mishra</given-names></name></person-group><source>Bhavaprakasha, Madhyama Khanda, Part-2, 36/41</source><year>2005</year><edition>9th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrita Sansthana</publisher-name><fpage>370</fpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sharangadhara</surname></name></person-group><person-group person-group-type="editor"><name><surname>Pandita P S</surname><given-names>Vidhyasagar</given-names></name></person-group><source>Sharangadhara Samhita</source><year>2006</year><edition>1st ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashana</publisher-name><fpage>212</fpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Vaidya Yadavaji</surname><given-names>Trikamji Aacharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita, Siddhi Sthana, Kalpana Siddhi, 1/20-21</source><year>2002</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrita Sansthana</publisher-name><fpage>680</fpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="webpage"><collab>International Prostate Symptom Score (I-PSS)</collab><date-in-citation>accessed on 2010 Apr 12</date-in-citation><comment>Available from: <uri xlink:type="simple" xlink:href="http://wwwurospec.com/uro/Forms/ipss.pdf">http://wwwurospec.com/uro/Forms/ipss.pdf</uri></comment></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Vaidya Yadavaji</surname><given-names>Trikamji Aacharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita, Viman Sthana, Rogabhishajitiya Vimanam, 8/122</source><year>2002</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrita Sansthana</publisher-name><fpage>280</fpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sushruta</surname></name></person-group><person-group person-group-type="editor"><name><surname>Vaidya Yadavaji</surname><given-names>Trikamji Aacharya</given-names></name></person-group><source>Sushruta Samhita, Sutra Sthana, Aturopakramaniya, 35/29</source><year>2008</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Surbharati Prakashana</publisher-name><fpage>155</fpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><collab>Ibidem</collab><source>Sushruta Samhita, Uttara Tantra, Mutraghata Pratishedhaahyaya, 58/26; 789</source></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="webpage"><collab>Guidelines on BPH, European Association of Urology</collab><year>2009</year><date-in-citation>accessed on 2010 Apr 25</date-in-citation><fpage>9</fpage><comment>Available from: <uri xlink:type="simple" xlink:href="http://www.uroweb.org/">http://www.uroweb.org/</uri></comment></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname></name></person-group><person-group person-group-type="editor"><name><surname>Vaidya Yadavaji</surname><given-names>Trikamji Aacharya</given-names></name></person-group><source>Charaka, Dridhabala, Charaka Samhita, Chikitsa Sthana, Trimarmiya Chikitsa, 26/32</source><year>2002</year><edition>Reprint</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrita Sansthana</publisher-name><fpage>599</fpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><collab>Ibidem</collab><source>Charaka Samhita, Chikitsa Sthana, Trimarmiya Chikitsa, 26/241-243; 610</source></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vasudevan Nampoothiri</surname><given-names>MR</given-names></name><name><surname>Mahadevan</surname><given-names>L</given-names></name></person-group><article-title>Principles and Practice of Vasti</article-title><year>2010</year><edition>3rd ed</edition><publisher-loc>Chennai</publisher-loc><publisher-name>Sri Sarada Ayurvedic Hospital Publication</publisher-name><fpage>46</fpage></element-citation></ref></ref-list></back></article>